Company news
07 February 2013 Alkor Bio Group has reached the First Rate among Fast-growing Russian Innovative Companies Final TechUspekhAt the end of 2012 there were finalized the results of the first Rating of fast-growing Russian innovative companies TechUspekh. Alkor Bio Group – the developer and manufacturer of laboratory diagnostics reagents – has become one among the finalists..
|
28 January 2013 Test kit "Cystic Fibrosis-BioChip" got an CE-markTest kit “Cystic Fibrosis-BioChip”, aimed for detection of 25 mutations in CFTR gene that are found at high frequency in Slavic population and are associated with Cystic Fibrosis development, got an CE-mark in January 2013.
|
24 December 2012 Alkor Bio Group video presentation |
07 December 2012 Alkor Bio Group has proved its adequacy to the international standards ISO 9001:2008 and ISO 13485:2003Alkor Bio Group has been successfully audited and has proved its adequacy to the requirements of ISO 9001:2008 and 13485:2003. The object of the audit was the system of Quality Management: production, infrastructure, documentation.
|
15 November 2012 "Neonatal NGS-based diagnostics" will be presented to the international scientific community
Sequoia Genetics Company (Alkor Bio Group) will take part in the
international conference “Postgenomic methods of analysis in biology, and
laboratory and clinical medicine” ,
which will be held in November 22-24 in Kazan, Russian Federation. Arseny
Smirnov, the leader of medical-genetic division of Sequoia Genetics, will
announce the report “NGS-based approach to the development of genetic assay of
4 inherited monogenic disorders”.
|
07 November 2012 Test kit "Cystic Fibrosis-BioChip" for the simultaneous detection of 25 mutations in the CFTR gene, Alkor Bio latest elaboration, had got the registration certificateOne of the latest elaborations of biotechnological group Alkor Bio – reagents kits “Cystic Fibrosis-BioChip”, aimed for molecular-genetic diagnostics of Cystic Fibrosis, got the registration certificate of Federal Service on Surveillance in Healthcare and Social Development of Russian Federation.
|